Cessatech Investor Relations Material
Latest events
Q2 2025
21 Aug, 2025
Q1 2025
15 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cessatech
Access all reports
Cessatech is a biopharmaceutical company developing non-invasive treatments for pain management, particularly in pediatric patients. It focuses on innovative anesthetic and analgesic formulations. The company is headquartered in Copenhagen, Denmark, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
CESSA
Country
🇩🇰 Denmark